Medicine International Special Issues

Comparative Oncology

Lead Editor:

    Dr Panayiotis Loukopoulos
    University of Melbourne

With a strong background, reseach and links in comparative oncology, and with strong collaboration and links with human oncology, veterinary oncology and One Health Research groups, including within his workplace at the University of Melbourne, the suggested Guest editor wishes to propose this theme as a potential topic to consider. Potential contributors will likely include researchers in both the human cancer research field, the veterinary cancer research field (animal cancer types often serving as excellent spontaneous models of human disease) as well as basic research into carcinogenesis. Several articles may focus on reviews of certain in vitro and in vivo models of human cancer, including spontaneous animal malignancies of species sharing the same environment as humans, such as caine osteosarcoma.

Submission deadline: 09 January 2024

One Health

Lead Editor:

    Dr Panayiotis Loukopoulos
    University of Melbourne

With a background in both wildlife pathology and comparative oncology, and with strong collaboration with One Health Research groups, including within his workplace at the University of Melbourne, the suggested Guest editor wishes to propose the theme of "One Health" as a potential topic to consider. The concept of One Health is defined by WHO ( ) as: " One Health is an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals and ecosystems. It recognizes that the health of humans, domestic and wild animals, plants, and the wider environment (including ecosystems) are closely linked and interdependent. While health, food, water, energy and environment are all wider topics with sector-specific concerns, the collaboration across sectors and disciplines contributes to protect health, address health challenges such as the emergence of infectious diseases, antimicrobial resistance, and food safety and promote the health and integrity of our ecosystems. By linking humans, animals and the environment, One Health can help to address the full spectrum of disease control – from prevention to detection, preparedness, response and management – and contribute to global health security. The approach can be applied at the community, subnational, national, regional and global levels, and relies on shared and effective governance, communication, collaboration and coordination. Having the One Health approach in place makes it easier for people to better understand the co-benefits, risks, trade-offs and opportunities to advance equitable and holistic solutions."

Submission deadline: 09 January 2024

Multi-omics Technologies for Precision Medicine

Lead Editor:

    Professor Chih-Yang Wang

Multi-Omics and bioinformatics are widely used as systemic approaches to explore differences in expressions of thousands of genes or metabolites for both basic and clinical research. Along with medical innovation to confront the challenges that originated from mitosis in cancer, there has been continuous improvement in paradigm for diseases screening as well as more promising treatment options across disease types to significantly improve patient outcomes, relying on breakthroughs in molecular profiling and high-throughput technologies. Since characteristics of tumors and changes in metabolic pathways that occur during malignant transformation and progression can be revealed by analyzing gene expression profiles. Single-cell RNA sequencing and mass spectrometry analyses, that allow the generation of large-scale data related to multi-omics analysis (such as genomics, transcriptomics, proteomics, phenomics, and metabolomics), are widely facilitated the discovery of significant biomarkers for early diagnosis and novel therapeutic targets of drugs, followed by intercepting premalignancy. Besides that, gene therapy, defined as an approach to treat gene-related disorders by modifying faulty genes via transferring therapeutic genetic materials into the cell, is also emerging as a promising treatment therapy for rare diseases and various cancers resulting from the presence of defective genes. Although the multi-omics data from bioinformatics analysis need to be confirmed via further detailed studies, it nonetheless helps to somehow foresee the trend of information for disease to develop. However, the bioinformatics data accompanied by validation experiments are also sought after.

Submission deadline: 04 July 2023

The epigenetics of chronic inflammation and related elderly diseases

Lead Editor:

    Dr Mohammed Al-obaide
    Texas Tech Univ. Health Sci Ctr
    United States

The world’s older population continues to grow at an unprecedented rate and are prone to chronic inflammation and associated diseases. It can hardly be said that that past years have explained the causes of chronic inflammation and related aging-associated diseases, e.g., cardiovascular disease, cancer, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension and Alzheimer's disease and others. Epigenetic factors, DNA methylation, noncoding RNA and histone modification are mediators of inflammation and chronic inflammatory disease. Intriguingly, epigenetics elements are influenced by environmental and nutritional factors. The aim of this special issue is to update the latest information related to epigenetics and environmental-nutritional factors related to chronic inflammation and associated elderly diseases.

Submission deadline: 07 June 2023

Technology in health sciences education

Lead Editor:

    Professor Carlos M. Ardila
    University of Antioquia

Technology continues to change healthcare education (and patient results) with new and innovative methods. Technology has also become a connection between universities, professors, undergraduates, and postgraduates. In addition to virtual lectures and online exams, patient simulations are present, as augmented reality, and other training mechanisms that prepare students to enter increasingly tech-heavy careers upon graduation. While few aptitudes trump lively observation, tech abilities and knowledge are on the rise. The integration of technology into health sciences curricula is thought to improve efficiency and enhance student experiences through active learning and interactive learning designs.

Submission deadline: 25 May 2023

Pharmacoepidemiology and Clinical pharmacology using big data in medicine.

Lead Editor:

    Dr Yoshihiro Noguchi
    Gifu Pharmaceutical University

The use of big data in medicine will enable the early detection of adverse events and pharmacological effects caused by single drugs or drug-drug interactions. Numerous pharmacoepidemiologists and clinical pharmacologists are already using big data to discover unknown adverse events and new pharmacological effects that were not revealed in pre-marketing clinical trials. These analysis cases will significantly contribute to the proper use of drugs. However, to obtain relevant analysis results, it is necessary to grasp and deepen our understanding of the characteristics and utilization limits of big data (databases) used in research. Therefore, this special issue focuses on actual analysis cases and data analysis methods using big data in pharmacoepidemiology and clinical pharmacology. In addition, big data studies covered in this special issue include not only studies using spontaneous reporting systems and claims databases but also studies using omics and in silico databases.

Submission deadline: 24 June 2023

Journal Cover

March-April 2023
Volume 3 Issue 2

Print ISSN: 2754-3242
Online ISSN: 2754-1304

Sign up for eToc alerts

Recommend to Library

Full Size Image